SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-004747
Filing Date
2020-01-23
Accepted
2020-01-23 19:31:56
Documents
1
Period of Report
2020-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7715
  Complete submission text file 0001209191-20-004747.txt   9017
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address
Cappel Markus J. (Reporting) CIK: 0001422995 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35420 | Film No.: 20543438